A univariate analysis in a large CRC cohort with known driver mutations and patient outcomes confirmed this relationship: CDX2 was prognostic in KRASWT tumors (Figure 3H-left), but not in KRASmut tumors (Figure 3H-right). The gene discussed is CDX2; the disease is colorectal carcinoma.